Citigroup »

Mersana Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-09-30 $156k 82k 1.89
2024-06-30 $52k 26k 2.01
2024-03-31 $1.9M 415k 4.48
2023-12-31 $37k 16k 2.32
2023-09-30 $2.2k 1.7k 1.27
2023-03-31 $2.1M 499k 4.11
2022-12-31 $1.6M 274k 5.86
2022-09-30 $1.3M 197k 6.76
2021-12-31 $1.4M 227k 6.22
2021-03-31 $3.7M 230k 16.18
2020-12-31 $352k 13k 26.64
2020-09-30 $72k 3.8k 18.73
2020-06-30 $611k 26k 23.41
2020-03-31 $59k 10k 5.81
2019-12-31 $41k 7.2k 5.70
2019-09-30 $4.0k 2.3k 1.72
2019-06-30 $37k 9.2k 4.00
2019-03-31 $17k 3.4k 5.04
2018-12-31 $14k 3.3k 4.23
2018-09-30 $28k 2.8k 9.94
2018-03-31 $1.0k 56 17.86
2017-12-31 $21k 1.3k 16.05
2017-09-30 $325k 19k 17.28